Home » C2 Therapeutics Receives CE Mark for Coldplay CryoBalloon
C2 Therapeutics Receives CE Mark for Coldplay CryoBalloon
C2 Therapeutics has received CE Mark for its Coldplay CryoBalloon Focal Ablation System.
The system directs cryoablation, a process that uses extreme cold to destroy or damage diseased tissue. Its cryotherapy diffuser is housed inside a self-sizing balloon.
The CryoBalloon has the potential to treat early Barrett’s neoplasia, which develops as a result of chronic injury from gastroesophageal reflux disease, the Redwood City, Calif.-based company says.
The product is available for commercial use initially in parts of Western Europe. — Michael Cipriano
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May